glp 1 agonist vs analog Frontiers GLP-1 Receptor Agonists: An Alternative
Description
doi: 10.2196/53619
While Im excited that patients may soon have more options, enthusiasm should not blind us to the risks
doi: 10.3389/fendo.2018.00402
For example, an insulin that modifies its action based on current glucose levels would be a significant advance for everyone who uses insulin, not just those with type 1 diabetes
